Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
Int J Mol Sci
; 20(6)2019 Mar 26.
Article
in En
| MEDLINE
| ID: mdl-30917505
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Diabetes Mellitus, Type 2
/
Hypoxia-Inducible Factor 1, alpha Subunit
/
Sirtuin 3
/
TOR Serine-Threonine Kinases
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Mol Sci
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: